Iovance Biotherapeutics, Inc. Common Stock (NASDAQ: IOVA) last traded at $8.29, down 7.79% on the session. The quote above updates while this page is open; the figures below are drawn from Iovance Biotherapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Iovance Biotherapeutics, Inc. Common Stock trades on NASDAQ under the ticker IOVA. Its market capitalisation is $3.76 billion.
Valuation measures for Iovance Biotherapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.76B |
|---|---|
| Enterprise value | $3.82B |
| Price / sales | 11.56 |
| Price / book | 5.10 |
| Beta | 1.26 |
Trailing-twelve-month figures tagged in Iovance Biotherapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $324.97M |
|---|---|
| Net income (TTM) | -$289.52M |
| EPS (TTM) | -$0.700 |
| Operating margin | -92.72% |
| Return on equity | -39.33% |
| Cash | $110.77M |
Range and volume for IOVA over the past 52 weeks.
| 52-week high | $9.36 |
|---|---|
| 52-week low | $1.76 |
| Volume | 27.70M |
| Average volume | 16.96M |
| Previous close | $8.99 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.